Premier Alternatives

Soley Therapeutics

South San Francisco, CA · Founded 2020 · Privately Held (backing)

Operator of a drug discovery platform intended to accelerate the development of therapies for complex diseases. Soley Therapeutics is based in South San Francisco, CA and was founded in 2020. It was valued at $700 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $290 million across 1 recorded round; the latest was a $20 million early-stage round in Oct 2020.

PMV mark · valuation
$700.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$290.0M
Last round
Early Stage VC
Oct 2020

Soley Therapeutics key facts

as of Oct 2026
  • Operator of a drug discovery platform intended to accelerate the development of therapies for complex diseases.
  • Soley Therapeutics is valued at approximately $700.0M as of Oct 2026, set at its later-stage round, Jul 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $290.0M across 1 recorded rounds; the latest was Early Stage VC ($20.0M) in Oct 2020.
  • Notable investors include Breyer Capital, Artisanal Ventures, Surveyor Capital, GordonMD Global Investments, RWN Management — 10 tracked in total.
  • Soley Therapeutics has filed 1 Form D with the SEC, most recently Dec 2020 ($20.0M sold to 32 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$700.0M

Valued at $700.0M at its later-stage round, Jul 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Soley Therapeutics with a free account
  • ·Watch Soley Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Soley Therapeutics funding rounds

1 rounds
Oct 2020Early Stage VC$20.0MSEC filing▮
Full funding history →

Soley Therapeutics valuation

Soley Therapeutics was valued at $700 million at its later-stage round in Jul 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Soley Therapeutics raised?

Soley Therapeutics has raised $290 million in total; 1 of its rounds is on record. The largest on record was a $20 million early-stage round in Oct 2020.

Soley Therapeutics has filed 1 Form D with the SEC, most recently in Dec 2020 ($20 million sold to 32 investors).

Soley Therapeutics investors

10 investors are on record for Soley Therapeutics, including Breyer Capital, Artisanal Ventures, Surveyor Capital and GordonMD Global Investments. The early-stage round in Oct 2020 drew 32 investors.

About Soley Therapeutics

Operator of a drug discovery platform intended to accelerate the development of therapies for complex diseases. The company offers an automated image-based technology using AI and machine learning to interpret cellular responses to compounds, enabling pharmaceutical and biotechnology researchers to identify drug candidates and improve decision-making across development programs.

Sector
Healthcare
HQ
South San Francisco, CA, United States
Founded
2020
Employees
39
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.